thanks Sdraw, the website had yesterdays date on it so it looked like new news.
So they inhibited telomerase but killed the patients? How come only two were analyzed for inhibition out of 42?
So are we screwed? Scarlett, tomorrow would be a good time to release any positive data since this trial was stopped due to deaths
im still unclear. scarlett said by end of year they would announce IF there was a change in dosage going forward. that insinuates that there are only 40 patients being dosed 20/20. but there are many more sites open and people on the message board are insinuating that there are a lot more than 40 patients being dosed now. the question is which is the truth. if there are only 40 how long will it take to get the rest of the patients? looking for real answers because no news for another year by this company is absolutely ridiculous
except that the way the stock acts, even if they get approved, no one here will have any confidence left that the stock will even go up on that news
and the stock is down 45% since December 31st. 45%
yeah that's because they did the secondary at $4/share years ago already :(